Zobrazeno 1 - 10
of 139
pro vyhledávání: ''
Autor:
M. Parrini, F. Simonetti, E. Banti, C. Camerini, L. Bozzoli, E. Sant’Antonio, V. Ciliberti, E. Capochiani, A. Ginori, M. Pellegri, C. De Gaudio
Publikováno v:
Tumori Journal. 107:NP127-NP130
Introduction: Posttransplant lymphoproliferative disorders (PTLDs) refer to a group of diseases, including diffuse large B-cell lymphoma (DLBCL), that develop after solid organ transplantation or hematopoietic stem cell transplantation. Extranodal in
Autor:
Nathalie Ausias, Patrice Vanelle, Fabrice Barlesi, Roch Giorgi, Marc Montana, Mathieu Peretti, Marie Eve Garcia, François Cavaille
Publikováno v:
Tumori
Tumori, 2021, 107 (1), pp.32-38. ⟨10.1177/0300891620926244⟩
Tumori, Casa Editrice Ambrosiana, 2020, pp.030089162092624. ⟨10.1177/0300891620926244⟩
Tumori, 2021, 107 (1), pp.32-38. ⟨10.1177/0300891620926244⟩
Tumori, Casa Editrice Ambrosiana, 2020, pp.030089162092624. ⟨10.1177/0300891620926244⟩
Background: Pembrolizumab, a humanized immunoglobulin monoclonal antibody directed against the programmed cell death 1 receptor, demonstrated robust efficacy and a manageable safety profile across multiple tumor types in clinical trials. Aim: To inve
Publikováno v:
Tumori Journal. 106:NP79-NP83
Background: Papillary renal cell carcinoma (pRCC) represents the second most common histologic subtype of renal cell carcinoma and comprises 2 subtypes. Prognosis for type 2 is associated with poor clinical outcome. Current guidelines are based on ph
Autor:
Giovanni Randon, Marco Maccauro, Melanie Claps, Filippo Pagani, Giulia Apollonio, Giorgia Peverelli, Giuseppe Procopio, Gianluca Aliberti, Alessandra Raimondi, Ettore Seregni, Pierangela Sepe, Elena Verzoni
Publikováno v:
Tumori Journal. 106:406-412
Introduction: Therapeutic decision-making in metastatic castration-resistant prostate cancer (mCRPC) represents an open challenge. Radium-223 is approved for patients with symptomatic bone metastases, no visceral involvement, progressing after at lea
Autor:
Bruno Fionda, Davide Cusumano, Rosa Autorino, Mario Balducci, Fabio Marazzi, Antonio Piras, Giuditta Chiloiro, Luca Boldrini, Francesco Cellini, M. Campitelli, Vincenzo Valentini, Maria Antonietta Gambacorta, Andrea D'Aviero
Publikováno v:
Tumori Journal. 106:497-505
Objective: Magnetic resonance–guided radiotherapy (MRgRT) represents an innovative approach for personalized radiotherapy treatments and its applications are being explored in various anatomical sites to fully understand its potential advantages. T
Autor:
Roberto Orecchia, Giulia Marvaso, Samantha Dicuonzo, Maria Cristina Leonardi, Barbara Alicja Jereczek-Fossa, E. Miglietta, Federica Cattani, Rosalinda Ricotti, Damaris Patricia Rojas
Publikováno v:
Tumori Journal. 106:518-523
Objective: To report treatment times (door to door) of adjuvant treatments of breast cancer (BC) with intensity-modulated radiotherapy (IMRT). Methods: Treatment times of 62 patients with BC on the TomoTherapy Hi-Art System were collected for the ana
Autor:
Donato Casella, Vieri Scotti, Livia Marrazzo, Icro Meattini, Lorenzo Orzalesi, Carlotta Becherini, Pietro Garlatti, Simonetta Bianchi, Jacopo Nori, Luis Jose Sanchez, Marco Bernini, Stefania Pallotta, Silvia Nesi, Lorenzo Livi, Isacco Desideri
Publikováno v:
Tumori Journal. 105:205-209
Introduction: For a long time, accelerated partial breast irradiation (APBI) effectiveness for ductal carcinoma in situ (DCIS) has been debated, due to conflicting published results. Recent encouraging data from phase 3 trials reopened new perspectiv
Publikováno v:
Tumori Journal. 105:509-515
Purpose: To investigate the efficacy of paclitaxel combined with a leucovorin and 5-fluorouracil regimen (PLF regimen; q2w) as neoadjuvant chemotherapy (NCT) for advanced gastric cancer. Methods: A total of 183 patients with advanced gastric cancer w
Autor:
Piergiacomo Calzavara-Pinton, Nadia Pasinetti, Mauro Urpis, Liliana Baushi, Carla Leali, Paolo Borghetti, Alessandra Tucci, Sara Pedretti, Luca Triggiani, Raffaella Sala, Diana Greco, Giuseppe Rossi, Michela Buglione, Stefano Maria Magrini
Publikováno v:
Tumori Journal. 104:394-400
Purpose: To analyze clinical outcome, local response, survival and toxicity in patients with primary cutaneous lymphoma (PCL) treated with radiotherapy. Methods: From 1995 to 2014, 112 patients were treated. B-cell lymphomas (CBCLs; n = 86) and T-cel
Autor:
Liang Chujia, Liu Junru, Li Junxun, Li Juan, Chen Shaoqian, Ye Zhuangjian, Zhan Jie-yu, Ouyang Juan, Chen Meilan, Cheng Jing, Zhang Fan
Publikováno v:
Tumori Journal. 102:S131-S136
Introduction Secondary lymphoblastic leukemia has been rarely reported in patients with multiple myeloma. Case Reports We report 3 cases of secondary lymphoblastic leukemia in multiple myeloma patients. They shared a similar phenotype of myeloma cell